�й�365bet���Ĺ���

WASHINGTON, March 21, 2011 �� The modern drug discovery process is the topic of the next in a series of American Chemical �й�365bet���Ĺ��� (ACS) Webinars�� for scientists and chemical professionals.

Scheduled for Thursday, March 24, from 2 �� 3 p.m., EDT, the free webinar features Terry Kenakin, a Director of Platform Technology Sciences at GlaxoSmithKline Research and Development in Research Triangle Park, North Carolina.

Participants will learn:

• Stages of the modern drug discovery process
• How pharmacokinetics and pharmacodynamics are used to guide discovery
• The primary assays used in discovery and development to guide optimization of efficacy and PK properties, what these assays give you, and how to interpret the data

Kenakin earned his B.S. in chemistry and Ph.D. in pharmacology at the University of Alberta, Canada. After three years at University College, London, UK, he joined Burroughs-Wellcome as a senior research pharmacologist. He then joined GlaxoSmithKline. Kenakin is the author of eight books on pharmacology including most recently, A Pharmacology Primer, Third Edition: Theory, Application and Methods. He is co-editor-in-chief of the International Journal of Receptors and Signal Transduction and Current Opinion in Pharmacology.

ACS Webinars�� feature experts and global thought leaders in the chemical sciences, management and business to address current topics of interest to scientific and engineering professionals. Each webinar includes a short presentation followed by a question and answer session. Scientists and others can tune into the conference without charge, but must in advance.

Follow ACS Webinars�� on Twitter@ACSWebinars or join group participants tweeting on this topic using #acswebinars hash-tag.

###